EV Biologics (YECO) News Today $0.25 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Best EV Stocks Of 2024July 25, 2024 | forbes.comChina Biologic ProductsJuly 20, 2024 | forbes.comHow Much Does It Cost to Charge an EV on a Road Trip?May 29, 2024 | investopedia.comWXIBF WuXi Biologics (Cayman) Inc.May 1, 2024 | seekingalpha.comNurExone Biologic Inc NRXBFMarch 22, 2024 | morningstar.comBest EV stocks in February 2024February 21, 2024 | usatoday.comSoft Tissue Biologics Product Pipeline Report 2023: Reveals Key Development Stages, Industry Trends, Regions, and CompaniesJanuary 24, 2024 | finance.yahoo.comFill Finish Manufacturing Market Forecast Report - A US$ 17.165 Billion Market by 2030, Amplified by Rising Demand for Prefilled SyringesJanuary 24, 2024 | finance.yahoo.comY Biologics Inc (338840)December 15, 2023 | uk.investing.comChinese EV startup WM Motor files for pre-restructuringOctober 17, 2023 | reuters.comEV Biologics Corporation: EV Biologics Updates on Funding and SalesOctober 4, 2023 | finanznachrichten.deEV Biologics Updates on Funding and SalesOctober 2, 2023 | finance.yahoo.comEV Biologics Completes Production of Cutting-Edge MSC Exosome-Based TherapeuticAugust 16, 2023 | finance.yahoo.comEV Biologics Appoints Senior Investment Banker as Corporate Finance DirectorAugust 7, 2023 | finance.yahoo.comHow the New EV Tax Credit Will Affect Your Auto LoanAugust 3, 2023 | money.usnews.comEV Biologics Corporation: EV Biologics Hires Senior Chief Financial OfficerAugust 2, 2023 | finanznachrichten.deEV Biologics Hires Senior Chief Financial OfficerAugust 2, 2023 | finance.yahoo.comToyota is planning a new EV with a 900-mile range and 10-minute charging time: ‘The holy grail of battery vehicles’July 30, 2023 | news.yahoo.comAre you a gas guzzler? The government might try to persuade you to switch to an EVJuly 16, 2023 | usatoday.comHow reliable are public EV charging stations? Report shows many EV drivers have issuesJune 21, 2023 | usatoday.comEV Biologics, Inc. (YECO)May 27, 2023 | finance.yahoo.comEV Biologics Corporation: EV Biologics Signs Exclusive Distribution Agreement for South AmericaMay 17, 2023 | finanznachrichten.deEV Biologics Signs Exclusive Distribution Agreement for South AmericaMay 15, 2023 | finance.yahoo.comBest EV Penny StocksMay 11, 2023 | benzinga.comGM to scrap Chevy Bolt, its most popular and least expensive EVApril 30, 2023 | washingtonpost.comTesco EV charging network reaches 600 UK stores – and rapid chargers go liveMarch 19, 2023 | a.msn.comEV Biologics Corporation: EV Biologics Generates Mesenchymal Stem Cell LinesFebruary 21, 2023 | finanznachrichten.deEV Biologics Generates Mesenchymal Stem Cell LinesFebruary 21, 2023 | finance.yahoo.comEV Biologics Corporation: EV Biologics Updates on Excyte Subsidiary FundingJanuary 3, 2023 | finanznachrichten.deEV Biologics Updates on Excyte Subsidiary FundingJanuary 3, 2023 | finance.yahoo.comThe Best Tires for Your EV Have 4 Unique ChallengesJanuary 2, 2023 | cnet.comEV Biologics Corporation: EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQXNovember 16, 2022 | finanznachrichten.deEV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQXNovember 14, 2022 | finance.yahoo.comEV Biologics Corporation: EV Biologics Launches Excyte with $100 million ValuationAugust 15, 2022 | finanznachrichten.deEV Biologics Launches Excyte with $100 million ValuationAugust 15, 2022 | finance.yahoo.comEV Biologics Corporation: EV Biologics Signs MSA with LONZA Cell & Gene TherapyMay 17, 2022 | finanznachrichten.deEV Biologics Corporation: EV Biologics Isolates Primary Cells for Nanoparticle Production & Accelerated Cell Line DevelopmentApril 12, 2022 | finanznachrichten.deEV Biologics Isolates Primary Cells for Nanoparticle Production & Accelerated Cell Line DevelopmentApril 12, 2022 | finance.yahoo.comEV Biologics Corporation: EV Biologics Updates on FINRA FilingsMarch 9, 2022 | finanznachrichten.deEV Biologics Updates on FINRA FilingsMarch 9, 2022 | finance.yahoo.comEV Biologics Corporation: EV Biologics Updates on FINRAJanuary 18, 2022 | finanznachrichten.deEV Biologics Updates on FINRAJanuary 18, 2022 | finance.yahoo.comEV Biologics Corporation: EV Biologics Updates on NFT DividendNovember 12, 2021 | finanznachrichten.deEV Biologics Updates on NFT DividendNovember 12, 2021 | finance.yahoo.comEV Biologics Corporation: EV Biologics Signs Listing Agreement With INXNovember 11, 2021 | finanznachrichten.deEV Biologics Signs Listing Agreement With INXNovember 11, 2021 | finance.yahoo.comEV Biologics Corporation: EV Biologics Chief Medical Officer Publication on COVID-19 & ExosomesOctober 28, 2021 | finanznachrichten.deEV Biologics Chief Medical Officer Publication on COVID-19 & ExosomesOctober 28, 2021 | finance.yahoo.comEV Biologics Corporation: EV Biologics Updates on NFT MintingSeptember 28, 2021 | finanznachrichten.deEV Biologics Updates on NFT MintingSeptember 28, 2021 | finance.yahoo.com Get EV Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for YECO and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention. Get your FREE, no-obligation Wealth Protection Guide now YECO Media Mentions By Week YECO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. YECO News Sentiment▼0.000.83▲Average Construction News Sentiment YECO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. YECO Articles This Week▼00▲YECO Articles Average Week Get EV Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for YECO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HIHO News Today FGI News Today AGRI News Today AREB News Today VAPR News Today BNRG News Today AREBW News Today CPAC News Today EPGRQ News Today MMMW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:YECO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EV Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EV Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.